0001179110-18-001861.txt : 20180208
0001179110-18-001861.hdr.sgml : 20180208
20180208201435
ACCESSION NUMBER: 0001179110-18-001861
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180206
FILED AS OF DATE: 20180208
DATE AS OF CHANGE: 20180208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vetticaden Santosh
CENTRAL INDEX KEY: 0001386932
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13111
FILM NUMBER: 18587291
MAIL ADDRESS:
STREET 1: C/O ADVENTRX PHARMACEUTICALS, INC.
STREET 2: 12390 EL CAMINO REAL, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEPOMED INC
CENTRAL INDEX KEY: 0001005201
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943229046
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-744-8000
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-06
0
0001005201
DEPOMED INC
DEPO
0001386932
Vetticaden Santosh
C/O DEPOMED INC.
7999 GATEWAY BOULEVARD, SUITE 300
NEWARK
CA
94560
0
1
0
0
SVP, Chief Medical Officer ***
Restricted Stock Units
2018-02-06
4
A
0
36800
0
A
Common Stock
36800
36800
D
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
These restricted stock units are scheduled to vest 33.33% on February 6, 2019, 33.33% on February 6, 2020 and 33.33% on February 6, 2021, assuming continued employment through the applicable vesting date.
*** Santosh's title is Senior Vice President, Chief Medical and Scientific Officer.
/s/ Santosh J. Vetticaden
2018-02-08